1.
Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways . Biomol Biomed [Internet]. 2023 May 1 [cited 2024 May 26];23(3):457–470. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/8549